<qa>  What is the name of the study drug used to treat 6 subjects for 12 months each?This study is being conducted to evaluate the safety and effectiveness of lenalidomide Revlimid in subjects with Cutaneous Lupus Erythematosus CLE. The study drug will be used in an off-label indication to treat 6 subjects for 12 months each. Men and women over the age of 18, who have a biopsy proven diagnosis of CLE and who have failed standard treatment, will be included in the study. 